Navigation Links
George Mason University professor receives $2.6 million NIH grant to study Alzheimer's disease
Date:9/25/2007

Fairfax, Va. (Sept. 25, 2007) George Mason University professor of psychology, Raja Parasuraman, has received a $2.6 million grant from the National Institutes of Health to conduct research regarding the detection and prevention of Alzheimer's disease. His program, "Apolipoprotein, Attention and Alzheimer's disease," will annually test more than 500 middle-aged and older adults for four years using cognitive, genetic and magnetic resonance imaging (MRI) tests to identify precursors of Alzheimer's disease.

According to the Alzheimer's Association, cases of Alzheimer's in the United States have risen from two million to five million in the last 10 years. By the year 2050, approximately one in every 45 Americans will be afflicted.

"The incidence of Alzheimer's is undergoing explosive growth," says Parasuraman. "In an effort to control this rapid growth, a major approach has been to examine individuals who are not affected, but who have an increased genetic risk for developing the disease later in life."

Apolipoprotein E (APOE) is an inherited gene that has been closely linked to the development of Alzheimer's. Though APOE is the strongest known genetic risk factor for Alzheimer's, only half of its carriers develop the disease by age 80. Parasuraman hopes to make advancements in early detection by identifying markers sensitive to APOE.

The five-year project will closely examine the effects of APOE on attention and memory in three groups of healthy adults -- ages 18 to 29, 40 to 59, and 60 to 75. Through a previously established collaborative relationship with a research group at the University of Oslo in Norway, one of the studies will be carried out by Ivar Reinvang, professor of clinical neuropsychology at the university. The older group will be tested at the University of Oslo because of the greater frequency of the APOE gene in Northern Europe.

"Though a project of this magnitude will take a great deal of time, eff
'/>"/>

Contact: Jim Greif
jgreif@gmu.edu
703-993-9118
George Mason University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. George Bush pledges 200 million dollars for AIDS relief
2. Arsenic May Have Been Responsible For The Madness Of King George III Of England
3. Study Unveils New Insight To The Madness Of King George III
4. Investigation into the Poor Hospital Facility That Led To the Death of George Cook
5. Georgetown University Heads Alternative Tobacco Project
6. Researchers at Cornell University as been reported using research fund by false claims
7. A new study by John Hopkins University proposes formula for good health
8. James Cook University urges more medical seats
9. Pill splitting program of University of Michigan can save money
10. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
11. Yale University guidelines for Physicians and Pharmaceutical industry

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQuality... Spare the Air Alert forThursday,Nov...ogsoranyothersolidfuel,bothindoorsandoutdoors. ,...ualitytomorrow,"saidJackBroadbent,executiveofficer...pectthehealthoftheirneighborsandfellowcommunitymem...
(Date:11/25/2009)... survivors of testicular cancer who were treated w...ide effects, including neurological side effects a...reated with chemotherapy, according to a new study...he National Cancer Institute . , Marianne Brydy,...iversity Hospital, in Bergen, Norway, and colleagu...
(Date:11/25/2009)...itous discovery that grew out of a collaboration b...ally offer hope to the nearly 10 million Americans..., Also known as hardening of the arteries, perip...atory problem in which narrowed arteries reduce bl... a red flag for vascular disease, heart attack and...
(Date:11/25/2009)...ollow-up period was too short to draw definite con...ov. 25 (HealthDay News) -- In diabetic patients wi...no difference in outcomes at one year whether pati...enting, British researchers report. , Bypass su... patients with coronary artery disease. However, l...
(Date:11/25/2009)... Evaluation and treatment clinics to... Woodstock (Vocus) November 25, 2009 -- Centegra H...cines and H1N1 vaccine shots at four Centegra Prim...hipment of vaccine has arrived. The clinics are at... McHenry and will be open as follows: ,  ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...1, 2009 AMERIGROUP Corporation (NYSE: AGP ) t...r the fourth quarter ended December 31, 2008, befo.... At 8:30 a.m. Eastern Time on the same day, AMER...domestic) or 706-679-7245 (international) approxim...
...n observance of National Children,s Dental Health ... Association (PDA) is sponsoring its annual poster...re eligible to participate in the contest. , , T...lic libraries. In addition to the student prize, t...
...ould detect virus that can lead to failure, , ... urine test that can detect a common cause of kidn...nosis and treatment of patients with polyomavirus ...ems for people with compromised immune systems. Pe...
...ticle pollution correlate with increases in life e...y News) -- A new study shows there is a direct rel...tants in the air people breathe and life expectanc... meter of air adds about seven months of life expe...
...thy infant feeding can help stem the staggering ri...tate University nursing professor who will use a $...r infant feeding program. , Mildred Horodynski of...ces, known as infant-centered feeding. , Her thre...
...Pharmaceuticals, Inc. (Nasdaq: AMLN ) will webca...urth quarter and full year 2008 on Tuesday, Januar... Bradbury, Amylin,s president and chief executive ...08. , , The call will be webcast live through A...
Other Medicine News:Health News:AMERIGROUP Corporation to Discuss Fourth Quarter Earnings on February 19 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Cleaner Air Equals Longer Life 2Health News:Cleaner Air Equals Longer Life 3Health News:MSU researcher receives $1.5 million grant for childhood obesity intervention study 2Health News:Amylin Pharmaceuticals to Webcast Year-End Results 2
(Date:11/24/2009)....24/PRNewswire-Asia/--ChindexInternational,Inc.,("...anproviderofWestern,healthcareproductsandservicesi...Companywillattendthe21stAnnualPiperJaffray,"Unplug...atthe,NewYorkPalaceHotel. , Managementiscurre...er1,2009,andholdone-on-onemeetingsthroughouttheday...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasdaq:...orticdisorders,announcedtodaythatithasfiledamotion...ingementlawsuitbroughtagainstitinOctober2009byCook...rtinIndianapolis,Indiana. ,, Endologixhasreques...tentandTrademarkOffice(USPTO)conductsproceedingsto...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3InterMune to Release Third Quarter Financial Results on November 5 14645 1InterMune to Release Third Quarter Financial Results on November 5 14645 2Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 1Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 2MedCath Corporation to Hold Conference Call on Fourth Quarter Results 5826 1MedCath Corporation to Hold Conference Call on Fourth Quarter Results 5826 2
...aluate Safety, Efficacy of Novel Cortisol ...ept. 26 DiObex, Inc., a privately held,biotechnol...tics to treat,metabolic diseases, announced today ...inical trial of DIO-902, a novel cortisol synthesi...e 2 diabetes mellitus (T2DM). The Phase 2b multin...
...ive Nasal Spray Dosage form is Patient Friendly ...ry Delivery -, BOTHELL, Wash., Sept. 26 Nastech,...nced today the start of a,Phase 2 clinical trial e...,Spray in approximately 20 patients with type 2 di... evaluating formulations of Insulin Nasal Spray,as...
Other Medicine Technology:DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 2DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 3Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 2Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 3
Fixed Core Straight Safety Wire Guides - Standard (PTFE coated)
Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
Fascial Incising Needles
Two-Part Trocar Needles - Standard
Medicine Products: